Cargando…
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors
Fyn tyrosine kinase inhibitors are considered potential therapeutic agents for a variety of human cancers. Furthermore, the involvement of Fyn kinase in signalling pathways that lead to severe pathologies, such as Alzheimer’s and Parkinson’s diseases, has also been demonstrated. In this study, start...
Autores principales: | Poli, Giulio, Lapillo, Margherita, Granchi, Carlotta, Caciolla, Jessica, Mouawad, Nayla, Caligiuri, Isabella, Rizzolio, Flavio, Langer, Thierry, Minutolo, Filippo, Tuccinardi, Tiziano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009924/ https://www.ncbi.nlm.nih.gov/pubmed/29747534 http://dx.doi.org/10.1080/14756366.2018.1469017 |
Ejemplares similares
-
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
por: Poli, Giulio, et al.
Publicado: (2019) -
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors
por: Granchi, Carlotta, et al.
Publicado: (2017) -
A Guide to PIN1 Function and Mutations Across Cancers
por: El Boustani, Maguie, et al.
Publicado: (2019) -
Application of MM-PBSA Methods in Virtual Screening
por: Poli, Giulio, et al.
Publicado: (2020) -
Sirtuin 1-Activating Compounds: Discovery of a Class of Thiazole-Based Derivatives
por: Bononi, Giulia, et al.
Publicado: (2022)